Overview

Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis

Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate if interferon beta is superior to the standard treatment with Methotrexate for the treatment of intermediate uveitis and macular edema.
Phase:
Phase 3
Details
Lead Sponsor:
Heidelberg University
Collaborator:
Serono GmbH
Treatments:
Interferon-beta
Interferons
Methotrexate